Drospirenone/estetrol

Drospirenone/estetrol is used as a combined birth control pill to prevent pregnancy in women. ==Side effects==

Estetrol-containing birth control pills, similarly to estradiol-containing birth control pills, may have a lower risk of venous thromboembolism (VTE) than ethinylestradiol-containing birth control pills based on studies of coagulation. However, it is likely that another decade will be required before post-marketing epidemiological studies of VTE incidence with these birth control pills are completed and able to confirm this. ==Pharmacology==

Pharmacodynamics Drospirenone/estetrol has a much lower impact on liver protein synthesis, including of sex hormone-binding globulin, angiotensinogen, and coagulation factors, than does ethinylestradiol/drospirenone. ==Society and culture==

Legal status Drospirenone/estetrol is approved for the use of hormonal contraception in the European Union, the United States, and Canada. Brand names Drospirenone/estetrol in sold under the brand names Nextstellis, Drovelis, and Lydisilka. ==See also==